Cumberland Pharmaceuticals (CPIX) Revenue (2010 - 2026)

Cumberland Pharmaceuticals (CPIX) has 17 years of Revenue data on file, last reported at $9.1 million in Q1 2026.

• For the quarter ending Q1 2026, Revenue fell 22.04% year-over-year to $9.1 million; the trailing twelve-month figure through Mar 2026 stood at $41.9 million (up 2.08% YoY), and the FY2025 full-year result was $44.5 million, up 17.57% from the prior year.
• Revenue slipped to $9.1 million in Q1 2026, from $13.7 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $13.7 million in Q4 2025 to a low of $8.3 million in Q3 2025.
• A 5-year average of $10.2 million and a median of $10.1 million in 2023 frame the typical range for Revenue.
• Across the five-year window, Revenue jumped 41.38% in 2022 and dropped 22.04% in 2026, its largest moves.
• Tracing CPIX's Revenue over 5 years: stood at $9.1 million in 2022, then advanced by 2.51% to $9.4 million in 2023, then climbed by 11.57% to $10.4 million in 2024, then soared by 31.08% to $13.7 million in 2025, then plunged by 33.24% to $9.1 million in 2026.
• Business Quant data shows CPIX's Revenue at $9.1 million in Q1 2026, $13.7 million in Q4 2025, and $8.3 million in Q3 2025.